Last reviewed · How we verify
NCT04111328
the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort
Phase 4 trial testing intravenous sufentanil in Analgesia, Patient-Controlled in 600 participants. Completed in 30 October 2020.
30 September 2020
Quick facts
| Lead sponsor | Jun Wang |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 600 |
| Start date | 8 October 2019 |
| Primary completion | 30 September 2020 |
| Estimated completion | 30 October 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- intravenous sufentanil — full drug profile →
- subcutaneous sufentanil
- intravenous hydromorphone — full drug profile →
- subcutaneous hydromorphone — full drug profile →
- intravenous sufentanil and dexmedetomidine — full drug profile →
- subcutaneous sufentanil and dexmedetomidine
- intravenous hydromorphone and dexmedetomidine — full drug profile →
- subcutaneous hydromorphone and dexmedetomidine
Conditions studied
- Analgesia, Patient-Controlled — all drugs for Analgesia, Patient-Controlled →
Sponsor
Jun Wang — full company profile →
Who can join
Adults 18 to 65, any sex, with Analgesia, Patient-Controlled. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the effect of different drugs and infusion ways on degree of postoperative comfort.Patients undergoing spinal neoplasm surgery receive different patient controlled analgesia(PCA) drugs postoperatively,one group is sufentanil,the other is hydromorphone. Then each drug group will be divided into two subgroups according to the infusion way,intravenously,subcutaneously. During the patient controlled analgesia period, patients' degree of comfort,pain score,sleep quality, the degree of side reaction will be recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04111328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of intravenous sufentanil
Trials testing the same drug.
- NCT07089173 — The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction Wit · NA · recruiting
Other recruiting trials for Analgesia, Patient-Controlled
Currently open trials in the same condition.
- NCT05672225 — Two-channel IV-PCA With Dexmedetomidine · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04111328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jun Wang
- Last refreshed: 9 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04111328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing